Suchergebnisse - "Young, Guy"

PubPharm (23)

1

Emicizumab prophylaxis in infants with hemophilia A (HAVEN 7) : primary analysis of a phase 3b open-label trial

enthalten in: Blood | 2024

von Pipe, S. | Collins, P. | Dhalluin, C. | +15

CommentIn: Blood. 2024 Apr 4;143(14):1317-1318. - PMID 38573607

2

Severe muscle bleeds in children and young adults with hemophilia A on emicizumab prophylaxis : Real-world retrospective multi-institutional cohort

enthalten in: American journal of hematology | 2023

von Batsuli, G. | Wheeler, A. | Weyand, A. | +2

3

Safety of FEIBA and emicizumab (SAFE) : Dose escalation study evaluating the safety of in vivo administration of activated prothrombin complex concentrate in haemophilia A patients on emicizumab

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2023

von Kizilocak, H. | Marquez-Casas, E. | Malvar, J. | +1

4

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis : experience from the HAVEN 1-4 studies

enthalten in: Blood advances | 2022

von Kruse-Jarres, R. | Peyvandi, F. | Oldenburg, J. | +16

5

Determining the approximate factor VIII level of patients with severe haemophilia A on emicizumab using in vivo global haemostasis assays

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2021

von Kizilocak, H. | Marquez-Casas, E. | Malvar, J. | +2

6

Emicizumab prophylaxis in infants with severe haemophilia A without inhibitors : Illustrative real-world cases to support shared decision-making

enthalten in: Haemophilia : the official journal of the World Federation of Hemophilia | 2021

von Mason, J. | Young, G.

7

Management of children with hemophilia A : How emicizumab has changed the landscape

enthalten in: Journal of thrombosis and haemostasis : JTH | 2021

von Young, G.

8

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies

enthalten in: Blood | 2021

von Callaghan, M. | Negrier, C. | Paz-Priel, I. | +17

CommentIn: Blood. 2021 Apr 22;137(16):2135-2136. - PMID 33885708

9

Safety evaluation of emicizumab prophylaxis in individuals with haemophilia A

enthalten in: Expert opinion on drug safety | 2021

von Wang, C. | Young, G. | Thornburg, C.

10

Pharmacokinetics and Pharmacodynamics of Emicizumab in Persons with Hemophilia A with Factor VIII Inhibitors : HAVEN 1 Study

enthalten in: Thrombosis and haemostasis | 2021

von Schmitt, C. | Adamkewicz, J. | Xu, J. | +6